Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Arch Oral Biol. 2012 Aug 29;58(4):348–354. doi: 10.1016/j.archoralbio.2012.08.003

Fig. 2.

Fig. 2

Paraffin sections of EMD–FITC treated HPDL fibroblasts probed with anti-20 kDa-amelogenin antibodies. Cells were counterstained with haematoxylin and eosin. Multiple, strongly cross-reactive VLSs were evident within the cytoplasm (arrowed). Inset shows negative control (no primary antibody). No significant cross-reactivity observed.